Approval · Notice of Compliance 1316 · 2000
SALOFALK: Notice of Compliance 1316
Issued May 3, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1316
- Date
- May 3, 2000
- Company
- Axcan Pharma Inc.Mont St-Hilaire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength - 1000mg
- Therapeutic class
- Lower gastrointestinal tract anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SALOFALK | 02242146 | Marketed |
Medicinal ingredients
- MESALAZINE 1,000 MG per SUP